5‐HYDROXYTRYPTAMINE AND DOPAMINE TRANSPORT BY RAT AND HUMAN BLOOD PLATELETS
Authors:
Open Access
- 1 February 1978
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 62 (2) , 219-226
Abstract
Uptake of 5‐hydroxytryptamine (5‐HT) by rat platelets in plasma was very rapid and diffusion did not contribute significantly at substrate concentrations that did not saturate the active transport. Under conditions which allowed measurement of initial rates of uptake, kinetic analysis revealed a high affinity uptake mechanism for 5‐HT (Km= 0.7 μM). Uptake of dopamine was relatively slow and involved a lower affinity (Km= 70 μM) active transport process. Diffusion contributed significantly at concentrations that did not saturate the active transport. 5‐HT competitively inhibited uptake of dopamine, andvice versa;Kivalues for both amines were similar to their respectiveKmvalues for uptake. Chlorimipramine, desmethylimipramine and benztropine were tested as uptake inhibitors. Each was equipotent against 5‐HT and dopamine, although the absolute potency of the drugs varied greatly. Chlorimipramine was the most potent (Ki≃ 100 nM), and kinetic analysis revealed that the inhibition was competitive against both 5‐HT and dopamine. Similar results were obtained in studies with human platelets:Kmvalues for 5‐HT and dopamine were about 1μM and 100 μM respectively. Activity profiles of inhibitors were also similar: each compound tested was equipotent against 5‐HT and dopamine, and the two amines each competitively inhibited uptake of the other. We conclude that dopamine is actively transported by platelets via the 5‐HT uptake mechanism, but with a much lower affinity. There is no high‐affinity dopamine‐specific mechanism corresponding to that in the corpus striatum. Consequently although platelets may be valid models of transport in 5‐hydroxytryptaminergic neurones, they should not be regarded as models for the dopamine transport mechanism found in dopaminergic neurones.Keywords
This publication has 27 references indexed in Scilit:
- Improved method for evaluating the inhibition of [14C]5-hydroxytryptamine uptake by rat plateletsJournal of Pharmacy and Pharmacology, 1976
- UPTAKE OF 5‐HYDROXYTRYPTAMINE BY RAT BLOOD PLATELETS AND ITS INHIBITION BY ADENOSINE 5‘‐DIPHOSPHATEBritish Journal of Pharmacology, 1976
- A new modification for studying 5-HT uptake by blood platelets: a re-evaluation of tricyclic antidepressants as uptake inhibitorsJournal of Pharmacy and Pharmacology, 1974
- Effects of nicotine on the uptake and retention of 14C-noradrenaline and 14C-5-hydroxytryptamine by rat brain homogenatesEuropean Journal of Pharmacology, 1973
- Blood platelets as a model for monoamine-containing neuronesProgress in Neurobiology, 1973
- Accumulation of dopamine by blood platelets from normal subjects and parkinsonian patients under treatment with l‐DOPABritish Journal of Pharmacology, 1970
- The inhibition of human platelet 5-hydroxytryptamine uptake by tricyclic antidepressive drugs. The relation between structure and potencyJournal of Pharmacy and Pharmacology, 1969
- Differential uptake of biogenic amines by isolated 5-hydroxytryptamine organelles of blood plateletsLife Sciences, 1969
- On the membrane effects of chlorpromazine: uptake of biologic amines by the blood platelet and red cellInternational Journal of Neuropharmacology, 1964
- The Determination of Enzyme Dissociation ConstantsJournal of the American Chemical Society, 1934